nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxymesterone—ESR1—ATF-2 transcription factor network—RB1—ocular cancer	0.00279	0.00279	CbGpPWpGaD
Fluoxymesterone—ESR1—FOXA1 transcription factor network—CDKN1B—ocular cancer	0.00275	0.00275	CbGpPWpGaD
Fluoxymesterone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—ocular cancer	0.00273	0.00273	CbGpPWpGaD
Fluoxymesterone—ESR1—FOXM1 transcription factor network—CCND1—ocular cancer	0.00272	0.00272	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of Androgen receptor activity—EP300—ocular cancer	0.0027	0.0027	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—E2F5—ocular cancer	0.00268	0.00268	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TFDP1—ocular cancer	0.00267	0.00267	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—CDKN1B—ocular cancer	0.00265	0.00265	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—CDK2—ocular cancer	0.00264	0.00264	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—E2F4—ocular cancer	0.00263	0.00263	CbGpPWpGaD
Fluoxymesterone—AR—Coregulation of Androgen receptor activity—CCND1—ocular cancer	0.00262	0.00262	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—RB1—ocular cancer	0.00261	0.00261	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK2—ocular cancer	0.0026	0.0026	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—RBL1—ocular cancer	0.00258	0.00258	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of Androgen receptor activity—MDM2—ocular cancer	0.00255	0.00255	CbGpPWpGaD
Fluoxymesterone—AR—Nongenotropic Androgen signaling—AKT1—ocular cancer	0.0025	0.0025	CbGpPWpGaD
Fluoxymesterone—ESR1—FOXM1 transcription factor network—EP300—ocular cancer	0.0025	0.0025	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—CDK4—ocular cancer	0.00249	0.00249	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—ocular cancer	0.00245	0.00245	CbGpPWpGaD
Fluoxymesterone—ESR1—Estrogen signaling pathway—AKT1—ocular cancer	0.00245	0.00245	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—CDKN1A—ocular cancer	0.00245	0.00245	CbGpPWpGaD
Fluoxymesterone—ESR1—FOXA1 transcription factor network—EP300—ocular cancer	0.00241	0.00241	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—E2F1—ocular cancer	0.00241	0.00241	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—EP300—ocular cancer	0.00233	0.00233	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—HDAC1—ocular cancer	0.00226	0.00226	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—MDM2—ocular cancer	0.00222	0.00222	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—SF3B1—ocular cancer	0.0022	0.0022	CbGpPWpGaD
Fluoxymesterone—ESR1—FOXM1 transcription factor network—MYC—ocular cancer	0.00218	0.00218	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.00218	0.00218	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—HDAC1—ocular cancer	0.00217	0.00217	CbGpPWpGaD
Fluoxymesterone—ESR1—LKB1 signaling events—MYC—ocular cancer	0.00214	0.00214	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MAML2—ocular cancer	0.00212	0.00212	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—ocular cancer	0.00211	0.00211	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—CDK2—ocular cancer	0.00208	0.00208	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—TFDP1—ocular cancer	0.00208	0.00208	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—ocular cancer	0.00207	0.00207	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—CCND1—ocular cancer	0.00207	0.00207	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—E2F5—ocular cancer	0.00206	0.00206	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—E2F1—ocular cancer	0.00206	0.00206	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of Androgen receptor activity—EP300—ocular cancer	0.00205	0.00205	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—E2F5—ocular cancer	0.00203	0.00203	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—MYC—ocular cancer	0.00203	0.00203	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—E2F4—ocular cancer	0.00202	0.00202	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—ocular cancer	0.00202	0.00202	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—HRAS—ocular cancer	0.002	0.002	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.002	0.002	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—E2F4—ocular cancer	0.00199	0.00199	CbGpPWpGaD
Fluoxymesterone—NR3C1—Circadian Clock—EP300—ocular cancer	0.00199	0.00199	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—RBL1—ocular cancer	0.00198	0.00198	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—CDK4—ocular cancer	0.00196	0.00196	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—RBL1—ocular cancer	0.00195	0.00195	CbGpPWpGaD
Fluoxymesterone—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—ocular cancer	0.00194	0.00194	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—ocular cancer	0.00194	0.00194	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—CDKN1B—ocular cancer	0.00194	0.00194	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—CCND1—ocular cancer	0.00194	0.00194	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—EP300—ocular cancer	0.00192	0.00192	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—EP300—ocular cancer	0.00191	0.00191	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—CDKN1B—ocular cancer	0.0019	0.0019	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—CDKN1A—ocular cancer	0.00187	0.00187	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—CDKN1B—ocular cancer	0.00187	0.00187	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—E2F1—ocular cancer	0.00186	0.00186	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—CCND1—ocular cancer	0.00185	0.00185	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—GNA11—ocular cancer	0.00185	0.00185	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—CCND1—ocular cancer	0.00181	0.00181	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—MDM2—ocular cancer	0.0018	0.0018	CbGpPWpGaD
Fluoxymesterone—ESR1—Validated nuclear estrogen receptor alpha network—EP300—ocular cancer	0.00179	0.00179	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—EP300—ocular cancer	0.00178	0.00178	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—CCND1—ocular cancer	0.00178	0.00178	CbGpPWpGaD
Fluoxymesterone—ESR1—LKB1 signaling events—TP53—ocular cancer	0.00176	0.00176	CbGpPWpGaD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—HRAS—ocular cancer	0.00175	0.00175	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.00172	0.00172	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—GNAQ—ocular cancer	0.00172	0.00172	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—CCND1—ocular cancer	0.00171	0.00171	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—RB1—ocular cancer	0.00171	0.00171	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—SF3B1—ocular cancer	0.0017	0.0017	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—ocular cancer	0.00169	0.00169	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.00168	0.00168	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—ocular cancer	0.00168	0.00168	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—SF3B1—ocular cancer	0.00167	0.00167	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—EP300—ocular cancer	0.00166	0.00166	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—MAML2—ocular cancer	0.00165	0.00165	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—EP300—ocular cancer	0.00164	0.00164	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.00163	0.00163	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CDK2—ocular cancer	0.0016	0.0016	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—TFDP1—ocular cancer	0.0016	0.0016	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—HRAS—ocular cancer	0.00159	0.00159	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—TFDP1—ocular cancer	0.00157	0.00157	CbGpPWpGaD
Fluoxymesterone—ESR1—Validated nuclear estrogen receptor alpha network—MYC—ocular cancer	0.00156	0.00156	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—ocular cancer	0.00156	0.00156	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—EIF1AX—ocular cancer	0.00155	0.00155	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—HDAC1—ocular cancer	0.00155	0.00155	CbGpPWpGaD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—AKT1—ocular cancer	0.00154	0.00154	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.00154	0.00154	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—ocular cancer	0.00153	0.00153	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—ocular cancer	0.00152	0.00152	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CDK4—ocular cancer	0.00151	0.00151	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—MYC—ocular cancer	0.00148	0.00148	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—EP300—ocular cancer	0.00148	0.00148	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—TGFB1—ocular cancer	0.00148	0.00148	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—RB1—ocular cancer	0.00146	0.00146	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—ocular cancer	0.00146	0.00146	CbGpPWpGaD
Fluoxymesterone—NR3C1—Endoderm Differentiation—TGFB1—ocular cancer	0.00146	0.00146	CbGpPWpGaD
Fluoxymesterone—AR—Coregulation of Androgen receptor activity—AKT1—ocular cancer	0.00146	0.00146	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—MDM2—ocular cancer	0.00146	0.00146	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—MYC—ocular cancer	0.00145	0.00145	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—TGFB1—ocular cancer	0.00145	0.00145	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—EP300—ocular cancer	0.00144	0.00144	CbGpPWpGaD
Fluoxymesterone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—ocular cancer	0.00144	0.00144	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—MYC—ocular cancer	0.00143	0.00143	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—TGFB1—ocular cancer	0.00142	0.00142	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CDKN2B—ocular cancer	0.00139	0.00139	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.00133	0.00133	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—RB1—ocular cancer	0.00132	0.00132	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—E2F5—ocular cancer	0.00129	0.00129	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—ocular cancer	0.00129	0.00129	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—E2F1—ocular cancer	0.00127	0.00127	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—ocular cancer	0.00127	0.00127	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—MAML2—ocular cancer	0.00127	0.00127	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—CCND1—ocular cancer	0.00127	0.00127	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—E2F4—ocular cancer	0.00126	0.00126	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.00125	0.00125	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—MAML2—ocular cancer	0.00125	0.00125	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—RBL1—ocular cancer	0.00124	0.00124	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—RPL39—ocular cancer	0.00124	0.00124	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.00121	0.00121	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—HDAC1—ocular cancer	0.00121	0.00121	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—EIF1AX—ocular cancer	0.00119	0.00119	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—MDM2—ocular cancer	0.00119	0.00119	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—TP53—ocular cancer	0.00119	0.00119	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—EIF1AX—ocular cancer	0.00118	0.00118	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—TP53—ocular cancer	0.00117	0.00117	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—EP300—ocular cancer	0.00117	0.00117	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—ocular cancer	0.00116	0.00116	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—EP300—ocular cancer	0.00114	0.00114	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—MDM2—ocular cancer	0.00112	0.00112	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—MDM2—ocular cancer	0.00112	0.00112	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.0011	0.0011	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CDKN1B—ocular cancer	0.00109	0.00109	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—CDKN2B—ocular cancer	0.00108	0.00108	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—HRAS—ocular cancer	0.00108	0.00108	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—AKT1—ocular cancer	0.00108	0.00108	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—RBBP4—ocular cancer	0.00108	0.00108	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.00105	0.00105	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—CDKN1A—ocular cancer	0.00105	0.00105	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—TP53—ocular cancer	0.00103	0.00103	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—AKT1—ocular cancer	0.00103	0.00103	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—CDKN1B—ocular cancer	0.00102	0.00102	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—MYC—ocular cancer	0.00102	0.00102	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.00102	0.00102	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CDKN1A—ocular cancer	0.001	0.001	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—TFDP1—ocular cancer	0.000999	0.000999	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—E2F5—ocular cancer	0.000994	0.000994	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—E2F5—ocular cancer	0.000979	0.000979	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CCND1—ocular cancer	0.000977	0.000977	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—E2F4—ocular cancer	0.000974	0.000974	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000968	0.000968	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—E2F4—ocular cancer	0.000959	0.000959	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—RPL39—ocular cancer	0.000955	0.000955	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—RBL1—ocular cancer	0.000955	0.000955	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—EP300—ocular cancer	0.000955	0.000955	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—AKT1—ocular cancer	0.000952	0.000952	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—RPL39—ocular cancer	0.000941	0.000941	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—RBL1—ocular cancer	0.000941	0.000941	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—CDKN1A—ocular cancer	0.000941	0.000941	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.00093	0.00093	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—HDAC1—ocular cancer	0.000929	0.000929	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—HDAC1—ocular cancer	0.000915	0.000915	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—EP300—ocular cancer	0.0009	0.0009	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—ocular cancer	0.000895	0.000895	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—ocular cancer	0.000881	0.000881	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—ocular cancer	0.000873	0.000873	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—TGFB1—ocular cancer	0.000868	0.000868	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—EP300—ocular cancer	0.000863	0.000863	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.000849	0.000849	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.000843	0.000843	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000841	0.000841	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—TP53—ocular cancer	0.000836	0.000836	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—CDKN2B—ocular cancer	0.000833	0.000833	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—RBBP4—ocular cancer	0.000828	0.000828	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—CDKN2B—ocular cancer	0.00082	0.00082	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—RBBP4—ocular cancer	0.000816	0.000816	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.00081	0.00081	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—MAML2—ocular cancer	0.000794	0.000794	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—MYC—ocular cancer	0.000784	0.000784	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000783	0.000783	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MDM2—ocular cancer	0.00077	0.00077	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—TFDP1—ocular cancer	0.00077	0.00077	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—TFDP1—ocular cancer	0.000758	0.000758	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000745	0.000745	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SAG—ocular cancer	0.00073	0.00073	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—AKT1—ocular cancer	0.000706	0.000706	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CDKN1B—ocular cancer	0.000703	0.000703	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000693	0.000693	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CCND1—ocular cancer	0.000671	0.000671	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—HRAS—ocular cancer	0.000654	0.000654	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.00065	0.00065	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CDKN1A—ocular cancer	0.000649	0.000649	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000648	0.000648	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—E2F5—ocular cancer	0.000646	0.000646	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—TP53—ocular cancer	0.000644	0.000644	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—E2F4—ocular cancer	0.000633	0.000633	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—RBL1—ocular cancer	0.000621	0.000621	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—EP300—ocular cancer	0.000617	0.000617	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—HRAS—ocular cancer	0.000613	0.000613	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—MAML2—ocular cancer	0.000612	0.000612	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—MAML2—ocular cancer	0.000602	0.000602	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000585	0.000585	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—HDAC1—ocular cancer	0.000581	0.000581	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—AKT1—ocular cancer	0.000577	0.000577	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—AKT1—ocular cancer	0.000544	0.000544	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—AKT1—ocular cancer	0.000541	0.000541	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—E2F3—ocular cancer	0.000538	0.000538	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MYC—ocular cancer	0.000538	0.000538	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TGFB1—ocular cancer	0.000537	0.000537	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000533	0.000533	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—CDKN2B—ocular cancer	0.00052	0.00052	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TFDP1—ocular cancer	0.000501	0.000501	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000451	0.000451	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—HDAC1—ocular cancer	0.000447	0.000447	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TP53—ocular cancer	0.000442	0.000442	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—HDAC1—ocular cancer	0.00044	0.00044	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—HRAS—ocular cancer	0.000423	0.000423	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—MYC—ocular cancer	0.000419	0.000419	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—CDKN2B—ocular cancer	0.000401	0.000401	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MAML2—ocular cancer	0.000398	0.000398	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—CDKN2B—ocular cancer	0.000395	0.000395	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—AKT1—ocular cancer	0.000373	0.000373	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GNA11—ocular cancer	0.000347	0.000347	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—MYC—ocular cancer	0.000323	0.000323	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GNAQ—ocular cancer	0.000323	0.000323	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—MYC—ocular cancer	0.000318	0.000318	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HDAC1—ocular cancer	0.000291	0.000291	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CDKN2B—ocular cancer	0.000261	0.000261	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—E2F1—ocular cancer	0.000239	0.000239	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—MYC—ocular cancer	0.000202	0.000202	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—MYC—ocular cancer	0.000155	0.000155	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—MYC—ocular cancer	0.000153	0.000153	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MDM2—ocular cancer	0.000145	0.000145	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—AKT1—ocular cancer	0.00014	0.00014	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CDKN1B—ocular cancer	0.000132	0.000132	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCND1—ocular cancer	0.000126	0.000126	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CDKN1A—ocular cancer	0.000122	0.000122	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—EP300—ocular cancer	0.000116	0.000116	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—AKT1—ocular cancer	0.000108	0.000108	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—AKT1—ocular cancer	0.000106	0.000106	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MYC—ocular cancer	0.000101	0.000101	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TGFB1—ocular cancer	0.000101	0.000101	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TP53—ocular cancer	8.3e-05	8.3e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HRAS—ocular cancer	7.93e-05	7.93e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—AKT1—ocular cancer	7.01e-05	7.01e-05	CbGpPWpGaD
